Centessa Pharmaceuticals plc
CNTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$236 | -$151 | -$216 | -$382 |
| Dep. & Amort. | $1 | $1 | $0 | $0 |
| Deferred Tax | $3 | -$27 | -$3 | $0 |
| Stock-Based Comp. | $34 | $29 | $25 | $0 |
| Change in WC | $22 | -$19 | -$3 | -$5 |
| Other Non-Cash | $34 | $6 | -$4 | $251 |
| Operating Cash Flow | -$142 | -$160 | -$201 | -$136 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $63 |
| Inv. Purchases | -$141 | -$265 | $0 | $0 |
| Inv. Sales/Matur. | $172 | $138 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $31 | -$127 | -$1 | $63 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1 | $0 | $0 | $74 |
| Stock Issued | $360 | $21 | $0 | $586 |
| Stock Repurch. | $0 | $0 | $0 | -$0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $6 | $0 | $0 | $0 |
| Financing Cash Flow | $365 | $21 | $0 | $660 |
| Forex Effect | $1 | $1 | -$0 | $3 |
| Net Chg. in Cash | $255 | -$266 | -$201 | $590 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $128 | $394 | $595 | $5 |
| End Cash | $383 | $128 | $394 | $595 |
| Free Cash Flow | -$142 | -$161 | -$202 | -$136 |